Company profile: Faculty Opinions
1.1 - Company Overview
Company description
- Provider of a discovery tool for qualitative assessment of published research, leveraging a faculty of over 8,000 leading life science and medicine experts who comment on and validate key publications. Offers H1 Connect for global health opportunities and training, H1 Profile to build credibility and apply, and a WhatsApp community for global peer collaboration.
Products and services
- H1 Connect: Global-scale platform that connects healthcare professionals to volunteer and medical deployment roles worldwide and supplies training resources for participation in global health work
- H1 Connect WhatsApp Community: WhatsApp-based network that enables healthcare professionals to connect and collaborate with peers globally through WhatsApp groups
- H1 Profile: Profile-centric feature where healthcare professionals create profiles to apply for global health opportunities and build credibility within the community
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Faculty Opinions
eMolecules
HQ: United States
Website
- Description: Provider of a free chemical structure search engine to search and order over 50M unique structures and 76M part numbers, including 4.5M building blocks and 20.3M screening compounds from 210+ suppliers. Offers compound reformatting, inventory management and global distribution, a virtual chemical space of over 4.9 trillion compounds for drug discovery, and structure data downloads for virtual screening, lead optimization, and cheminformatics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eMolecules company profile →
Teckro
HQ: United States
Website
- Description: Provider of mobile-first clinical research technology and services, including an app for real-time data capture and study interaction; site engagement assessment with reports and insights; a communications playbook; support for study enrollment and patient retention; and tools for protocol adherence with immediate access to current protocols and expert guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Teckro company profile →
GoSilico
HQ: Germany
Website
- Description: Provider of downstream simulation software for the biopharmaceutical industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GoSilico company profile →
BEKHealth
HQ: United States
Website
- Description: Provider of AI-powered chart abstraction and patient-matching solutions that analyze structured and unstructured EMR data to optimize clinical trial enrollment. Services include an automated ETL pipeline via proprietary EMR adapters, an AI data platform to standardize and translate medical data, patient matching, study rescue, and sponsor–site matching.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BEKHealth company profile →
Ampersand Biomedicines
HQ: United States
Website
- Description: Provider of programmable medicines and platforms that precisely target disease sites, including AND-Body Therapeutics for disease-specific precision and modification; the AND-Platform, a computational and experimental system enabled by a proprietary Address Map; the Opportunity Atlas for identifying localized targets; and enhanced biologic generation via AbCheck’s antibody discovery technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampersand Biomedicines company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Faculty Opinions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Faculty Opinions
2.2 - Growth funds investing in similar companies to Faculty Opinions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Faculty Opinions
4.2 - Public trading comparable groups for Faculty Opinions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →